Using poorly immunogenic mice with metastases (mammary carcinoma 4T1) as a model, the authors found that 9H10 (monoclonal antibody against CTLA-4) alone did not have an effect on the primary tumor and RT alone delayed tumor growth. This evidence concerns the gene CTLA4 and neoplasm.